NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 4 filers reported holding NOVAVAX INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $27,000 | +8.0% | 48,598 | +155.7% | 0.00% | – |
Q2 2018 | $25,000 | -16.7% | 19,003 | -21.4% | 0.00% | -100.0% |
Q4 2017 | $30,000 | -63.4% | 24,180 | -66.5% | 0.00% | -85.7% |
Q3 2017 | $82,000 | +15.5% | 72,254 | +17.6% | 0.01% | -50.0% |
Q2 2017 | $71,000 | -90.5% | 61,453 | -83.0% | 0.01% | -94.5% |
Q3 2016 | $751,000 | – | 360,840 | – | 0.26% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BB BIOTECH AG | 8,330,000 | $10,496,000 | 0.39% |
Alden Global Capital LLC | 640,500 | $807,000 | 0.28% |
Quantitative Investment Management, LLC | 3,784,100 | $4,767,000 | 0.12% |
Eventide Asset Management | 1,449,700 | $1,827,000 | 0.12% |
Bellevue Group AG | 325,000 | $410,000 | 0.08% |
Virtus ETF Advisers LLC | 196,162 | $247,000 | 0.07% |
Rock Springs Capital Management LP | 820,000 | $1,033,000 | 0.07% |
Quantbot Technologies LP | 462,250 | $582,000 | 0.06% |
Traynor Capital Management, Inc. | 43,361 | $55,000 | 0.04% |
Tekla Capital Management LLC | 571,000 | $719,000 | 0.03% |